Back

Comparative Analysis of Commercial Single-Cell RNA Sequencing Technologies

De Simone, M.; Hoover, J.; Lau, J.; Bennett, H.; Wu, B.; Chen, C.; Menon, H.; Au-Yeung, A.; Lear, S.; Vaidya, S.; Shi, M.; Lund, J. M.; Xavier-Magalhaes, A.; Liang, Y.; Kurdoglu, A.; O'Gorman, W. E.; Modrusan, Z.; Le, D.; Darmanis, S.

2024-06-18 molecular biology
10.1101/2024.06.18.599579 bioRxiv
Show abstract

This study evaluates ten commercially available single-cell RNA sequencing (scRNA-seq) approaches across four technology groups: Emulsion-based kits from 10x Genomics and Fluent Biosciences; Microwell-based kits from Becton Dickinson, Honeycomb Technologies and Singerlon Technologies; Combinatorial-indexing kits from Parse Biosciences and Scale Biosciences; and a Matrigel-based kit from Scipio Biosciences. Peripheral blood mononuclear cells (PBMCs) from a single donor were used to assess analytical performance. Key features such as sample compatibility, cost, and experimental duration were also compared. Notably, superior analytical performance was demonstrated by the Chromium Fixed RNA Profiling kit from 10x Genomics, which uniquely features probe hybridization for transcript detection. Additionally, the Rhapsody WTA kit from Becton Dickinson provided a cost-effective balance of performance and expense per cell. With a rich dataset of 218,154 cells, this work provides a basis for differentiating commercial scRNA-seq technologies, which is intended to facilitate the effective application and further methodological development of single cell transcriptomics.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.